Management of patients with hypertension and chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. On behalf of the European Society of Hypertension Working Group on Hypertension and the Kidney.

Autor: Halimi JM; Service de Néphrologie-Hypertension, Dialyses, Transplantation rénale, Hôpital Bretonneau, Tours, France., Sarafidis P; School of Medicine, Aristotle University of Thessaloniki, Greece., Azizi M; Université Paris Cité Department of Cardiology, Paris, France.; APHP, Service d'Hypertension Artérielle, Hôpital Européen Georges Pompidou, Paris, France., Bilo G; Grzegorz Bilo, Department of Cardiology, Istituto Auxologico Italiano, IRCCS, Milan, Italy.; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy., Burkard T; Medical Outpatient Department and Hypertension Clinic, University Hospital Basel, Basel, Switzerland., Bursztyn M; Hypertension Clinic, Hadassah-Hebrew University Medical Center, Mount Scopus, Jerusalem.; Faculty of Medicine, School of Medicine, Hadassah-Hebrew University, Jerusalem, Israel., Camafort M; Hypertension Unit, Department of Internal Medicine, Hospital Clinic, University of Barcelona, Spain., Chapman N; Peart-Rose Clinic, Hammersmith Hospital, Imperial College Healthcare Trust, London, UK., Cottone S; PROMISE Department, Nephrology and Dialisys Unit with Hypertension ESH Excellence Centre, University Hospital P.Giaccone, Palermo, Italy.; University of Palermo Department of Nephrology, Palermo, Italy., de Backer T; Department of Cardiovascular Diseases, Internal Medicine, University Hospital Ghent, Ghent, Belgium., Deinum J; Department of Medicine, Radboud University Medical Center, Nijmegen, the Netherlands., Delmotte P; Hypertension Unit (European Society of Hypertension Excellence Centre), Department of Cardiology, HELORA University Hospitals, Mons, Belgium., Dorobantu M; Emergency Clinical Hospital of Bucharest Department of Emergency Medicineap: Department of Cardiology, Bucharest, Romania., Doumas M; 2nd Prop Department of Internal Medicine, Aristotle University, Thessaloniki, Greece., Dusing R; Hypertoniezentrum Bonn, Schwerpunktpraxis Kardiologie, Angiologie, Prävention, Rehabilitation, Bonn, Germany., Duly-Bouhanick B; Service d'HTA et Therapeutique CHU Rangueil, Toulouse University, Toulouse, France., Fauvel JP; Department of Nephrology and Hypertension, Hôpital Ed Herriot, Lyon, France., Fesler P; Department of Internal Medicine, Montpellier University Hospital, Montpellier, France.; PhyMedExp, INSERM U1046, CNRS UMR 9214, University of Montpellier, Montpellier, France., Gaciong Z; Department of Internal Medicine, Hypertension and Vascular Diseases, Medical University of Warsaw, Warsaw, Poland., Gkaliagkousi E; 3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Greece., Gordin D; Department of Nephrology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland., Grassi G; Clinica Medica, University Milano Bicocca, Milan, Italy., Grassos C; Hypertension Unit, KAT General Hospital of Attica, Greece., Guerrot D; Service de Néphrologie, CIC-CRB 1404, INSERM EnVi U1096, CHU Rouen, France., Huart J; Division of Nephrology, University of Liège Hospital (ULg CHU), University of Liège, and Groupe Interdisciplinaire de Génoprotéomique Appliquée (GIGA), Cardiovascular Sciences, University of Liège, Liège, Belgium., Izzo R; Department of Advanced Medical Sciences, Federico II University of Naples, Italy., Jaén Águila F; Vascular Risk Unit, Internal Medicine, Virgen de las Nieves University Hospital, Granada, Spain., Járai Z; South-Buda Center Hospital, St. Imre University Teaching Hospital, Budapest, Hungary., Kahan T; Department of Clinical Sciences, Division of Cardiovascular Medicine, Karolinska Institute, Stockholm, Sweden.; Department of Cardiology, Danderyd University Hospital Corp, Stockholm, Sweden., Kantola I; Division of Medicine, Turku University Hospital, Turku University, Turku, Finland., Kociánová E; First Department of Internal Medicine - Cardiology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic., Limbourg F; Dept. of Nephrology and Hypertension, Hypertension Center, Hannover Medical School, Hannover, Germany., Lopez-Sublet M; AP-HP, Unité d'hypertension artérielle, service de médecine interne, Hôpital Avicenne, Bobigny, France.; INSERM UMR 942 MASCOT, Paris 13-Université Paris Nord, FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Bobigny, France., Mallamaci F; Grande Ospedale Metropolitano, UOC di Nefrologia abilitata al trapianto renale, CNR Epidemiologia Clinica e Fisiopatologia delle Malattie Renali e dell'Ipertensione Arteriosa, Reggio Calabria, Italy., Manolis A; Metropolitan Hospital, Piraeus, Greece., Marketou M; Hypertension Outpatient Clinic, Cardiology Department, Heraklion University General Hospital, Heraklion, Greece., Mayer G; Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck Anichstrasse, Innsbruck, Austria., Mazza A; Internal Medicine Unit, Department of Medicine, ESH Excellence Center Unit, Italy., MacIntyre I; Cardiovascular Risk Clinic, Western General Hospital, Edinburgh, UK., Mourad JJ; Service de Médecine Interne, Hôpital Franco-Britannique, Levallois-Perret, France., Muiesan ML; Centro Studi Diagnosi e Cura dell'Ipertensione Arteriosa e del Rischio Cardiovascolare (IARC), University of Brescia and ASST Spedali Civili, Italy., Nasr E; St George University Medical Center Achrafieh-Beirut, Lebanon., Nilsson P; Department of Clinical Sciences, Lund University, Skane University Hospital, Malmö, Sweden., Oliveras A; Hypertension and Vascular Risk Unit, Department of Nephrology, Hospital del Mar, IMIM (Hospital del Mar Medical Research Institute), Universitat Pompeu Fabra, Barcelona, Spain., Ormezzano O; UF Hypertension et Athérothrombose, Centre Européen d'Excellence en Hypertension Artérielle, Service de Cardiologie, CHU Michallon, Grenoble, France., Paixão-Dias V; Internal Medicine Department, Hospital Centre of Vila Nova de Gaia/Espinho, Portugal., Papadakis I; Hypertension Unit, Dept. of Internal Medicine, University Hospital of Heraklion, Heraklion, Greece., Papadopoulos D; ESH Excellent Center Hypertension, LAIKO University Hospital, Athens, Greece., Perl S; Department of Cardiology, Medical University of Graz, Graz, Austria., Polónia J; Department of Medicine CINTESIS RISE, Faculty of Medicine of Porto, Portugal., Pontremoli R; Università degli Studi e IRCCS Ospedale Policlinico San Martino di Genova, Italy., Pucci G; Department of Medicine and Surgery, University of Perugia, Unit of Internal Medicine - Santa Maria Terni Hospital, Terni, Italy., Robles NR; Badajoz, Spain., Rubin S; Service de Néphrologie-transplantation-dialyse-aphérèses, CHU Bordeaux, France., Ruilope LM; Cardiovascular Risk and Hypertension, Madrid, Spain., Rump LC; Department of Internal Medicine/Nephrology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany., Saeed S; Department of Heart Disease, Haukeland University Hospital, Bergen, Norway., Sanidas E; Department of Cardiology, LAIKO General Hospital, Athens, Greece., Sarzani R; Università Politecnica delle Marche and IRCCS-INRCA Department of Clinical and Molecular Sciences, Ancona, Italy., Schmieder R; Department of Nephrology, Hypertension University Hospital Erlangen, Friedrich Alexander University Erlangen/Nürnberg, Germany., Silhol F; Service de Médecine Vasculaire et Hypertension Artérielle, Centre de compétence régional des maladies artérielles rares, Centre d'excellence Européen en Hypertension Artérielle 264, rue Saint Pierre, CHU Timone, Marseille, France., Sokolovic S; Plava Medical Group, Sarajevo, Bosnia and Herzegovina., Solbu M; University Hospital of North Norway Department of Nephrology cb: Department of Internal Medicine and Cardiology, Tromsø, Norway., Soucek M; 2nd Department of Internal Medicine, St. Anne's University Hospital, Brno, Czech Republic.; Fakulty of Medicine, Masaryk University Brno, Czech Republic., Stergiou G; School of Medicine, Third Department of Medicine, Sotiria Hospital, Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, Athens, Greece., Sudano I; University Hospital Zurich University Heart Center, Cardiology and University of Zurich, Zurich, Switzerland., Tabbalat R; Department of Cardiology, Abdali Hospital, Amman, Jordan., Tengiz I; Division of Cardiology, Izmir Medicana International Hospital, Yenisehir, Turkey., Triantafyllidi H; 2nd Department of Cardiology, Medical School, University of Athens, ATTIKON Hospital, Athens, Greece., Tsioufis K; 1st Department of Cardiology, National and Kapodistrian University of Athens, Hippocratio Hospital, Greece., Václavík J; Department of Internal Medicine and Cardiology, University Hospital Ostrava, Czech Republic.; Faculty of Medicine, University of Ostrava, Czech Republic., van der Giet M; Medinische Klinik für Nephrologie und internistische Intensivtherapie, Charité - Universitätsmedizin Berlin, Berlin, Germany., der Niepen PV; Departement of Nephrology & Hypertension, Universitair Ziekenhuis Brussel Department of Nephrology and Hypertension, VUB, Belgium., Veglio F; Department of Medical Sciences, University of Turin, Italy., Venzin R; Department of Nephrology, Cantonal Hospital Graubuenden, Chur, Switzerland., Viigimaa M; Centre of Cardiology, North Estonia Medical Centre, Tallinn University of Technology, Tallinn, Estonia., Weber T; Cardiology Department, Klinikum Wels-Grieskirchen, Wels, Austria., Widimsky J; IIIrd Internal Department, Centre for Hypertension, General Faculty Hospital, Charles University, Prague, Czech Republic., Wuerzner G; Service de néphrologie et d'hypertension, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Zelveian P; Center of Preventive Cardiology, Armenia Parounak Zelveian, Hospital N2 CJSC, Yerevan, Armenia., Zebekakis P; Hypertension Unit of the First Department of Medicine, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece., Lueders S; St. Josefs Hospital, Cloppenburg, Germany., Persu A; Department of Cardiovascular Diseases, Division of Cardiology, Cliniques Universitaires Saint-Luc and Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium., Kreutz R; Institute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Vogt L; Department of Internal Medicine, Section of Nephrology, Amsterdam University Medical Center, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, the Netherlands.
Jazyk: angličtina
Zdroj: Blood pressure [Blood Press] 2024 Dec; Vol. 33 (1), pp. 2368800. Date of Electronic Publication: 2024 Jun 23.
DOI: 10.1080/08037051.2024.2368800
Abstrakt: Objective Real-life management of patients with hypertension and chronic kidney disease (CKD) among European Society of Hypertension Excellence Centres (ESH-ECs) is unclear : we aimed to investigate it. Methods A survey was conducted in 2023. The questionnaire contained 64 questions asking ESH-ECs representatives to estimate how patients with CKD are managed. Results Overall, 88 ESH-ECS representatives from 27 countries participated. According to the responders, renin-angiotensin system (RAS) blockers, calcium-channel blockers and thiazides were often added when these medications were lacking in CKD patients, but physicians were more prone to initiate RAS blockers (90% [interquartile range: 70-95%]) than MRA (20% [10-30%]), SGLT2i (30% [20-50%]) or (GLP1-RA (10% [5-15%]). Despite treatment optimisation, 30% of responders indicated that hypertension remained uncontrolled (30% (15-40%) vs 18% [10%-25%]) in CKD and CKD patients, respectively). Hyperkalemia was the most frequent barrier to initiate RAS blockers, and dosage reduction was considered in 45% of responders when kalaemia was 5.5-5.9 mmol/L. Conclusions RAS blockers are initiated in most ESH-ECS in CKD patients, but MRA and SGLT2i initiations are less frequent. Hyperkalemia was the main barrier for initiation or adequate dosing of RAS blockade, and RAS blockers' dosage reduction was the usual management.
Databáze: MEDLINE